Viewing data from:

TRIVORA-21

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A074538 | DR REDDYS LABORATORIES SA

2 strengths0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Trivora-28 (2023)

Total Spending

$35K

Total Claims

1,191

Beneficiaries

224

Avg Cost/Unit

$0.60

Spending Trend

$32K(2019)→$31K(2020)→$30K(2021)→$39K(2022)→$35K(2023)

YoY Change:-0.4%

5yr CAGR:-2.5%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (2)

Sort:

#001 — 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG

0 patents0 exclusivities▴

TABLET;ORAL-21 | Approved: Dec 18, 1997

No patent or exclusivity listings for this strength.

#002 — 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG

0 patents0 exclusivities▾

TABLET;ORAL-28 | Approved: Dec 18, 1997